SRS Capital Advisors Inc. Lowers Stock Position in IMAX Co. (NYSE:IMAX)

SRS Capital Advisors Inc. reduced its position in shares of IMAX Co. (NYSE:IMAX) by 37.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,061 shares of the company’s stock after selling 2,431 shares during the period. SRS Capital Advisors Inc.’s holdings in IMAX were worth $61,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Swiss National Bank increased its position in shares of IMAX by 8.5% during the 3rd quarter. Swiss National Bank now owns 102,000 shares of the company’s stock valued at $1,971,000 after purchasing an additional 8,000 shares during the last quarter. Mizuho Markets Americas LLC purchased a new position in IMAX in the third quarter valued at about $7,118,000. Mutual of America Capital Management LLC grew its position in shares of IMAX by 44.0% during the 4th quarter. Mutual of America Capital Management LLC now owns 158,022 shares of the company’s stock valued at $2,373,000 after acquiring an additional 48,266 shares during the period. Alpine Woods Capital Investors LLC increased its stake in shares of IMAX by 33.8% during the 3rd quarter. Alpine Woods Capital Investors LLC now owns 392,278 shares of the company’s stock worth $7,579,000 after purchasing an additional 99,163 shares during the last quarter. Finally, GTS Securities LLC bought a new stake in shares of IMAX in the third quarter valued at $1,092,000. 93.51% of the stock is currently owned by hedge funds and other institutional investors.

IMAX Price Performance

Shares of IMAX stock opened at $16.71 on Friday. IMAX Co. has a 1 year low of $13.20 and a 1 year high of $20.70. The firm has a market cap of $879.28 million, a price-to-earnings ratio of 34.81, a PEG ratio of 1.38 and a beta of 1.22. The company has a 50-day moving average of $16.53 and a 200 day moving average of $16.01.

IMAX (NYSE:IMAX) last announced its earnings results on Thursday, April 25th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. IMAX had a net margin of 7.13% and a return on equity of 9.47%. The business had revenue of $79.12 million during the quarter, compared to the consensus estimate of $77.88 million. On average, equities analysts anticipate that IMAX Co. will post 0.61 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Calamera Pablo sold 6,130 shares of IMAX stock in a transaction dated Friday, April 26th. The stock was sold at an average price of $17.05, for a total value of $104,516.50. Following the completion of the transaction, the executive vice president now owns 42,269 shares of the company’s stock, valued at approximately $720,686.45. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, VP Robert D. Lister sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $16.87, for a total value of $421,750.00. Following the completion of the transaction, the vice president now directly owns 138,889 shares in the company, valued at approximately $2,343,057.43. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Calamera Pablo sold 6,130 shares of the stock in a transaction on Friday, April 26th. The shares were sold at an average price of $17.05, for a total value of $104,516.50. Following the sale, the executive vice president now owns 42,269 shares in the company, valued at $720,686.45. The disclosure for this sale can be found here. Corporate insiders own 24.33% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on IMAX shares. Benchmark restated a “buy” rating and set a $22.00 target price on shares of IMAX in a research report on Friday, April 26th. Rosenblatt Securities lowered their price objective on shares of IMAX from $30.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, February 13th. Wedbush restated an “outperform” rating and issued a $22.00 target price on shares of IMAX in a research report on Friday, April 26th. The Goldman Sachs Group lowered their target price on IMAX from $15.00 to $13.00 and set a “sell” rating for the company in a research note on Thursday, January 11th. Finally, Barrington Research reissued an “outperform” rating and set a $24.00 price target on shares of IMAX in a research report on Monday, April 22nd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $20.57.

IMAX Company Profile

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.